Zobrazeno 1 - 10
of 195
pro vyhledávání: '"Jianrong Wu"'
Autor:
Ahmed Ragab, Lowell Anthony, Jianrong Wu, Aman Chauhan, M. Elizabeth Oates, Aurela Clark, Xue Ding, Riham H. El Khouli, Blaine T. Mischen
Publikováno v:
Academic Radiology. 29:95-106
Rationale and Objectives Standardized Uptake Value (SUV) is an important semiquantitative measurement used in the clinical and research domains to assess radiopharmaceutical concentration in tumors versus normal organs, but is susceptible to many fac
Autor:
Yini Chen, Jianrong Wu, Hairong Liu, Yan Wang, Yuanyi Zheng, Bing Hu, Junnian Hao, Jian Shen, Xiaojun Cai
Publikováno v:
Journal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-16 (2021)
Journal of Nanobiotechnology
Journal of Nanobiotechnology
Background The risk of local recurrence after high-intensity focused ultrasound (HIFU) is relatively high, resulting in poor prognosis of malignant tumors. The combination of HIFU with traditional chemotherapy continues to have an unsatisfactory outc
Publikováno v:
Pharm Stat
For the cancer clinical trials with immunotherapy and molecularly targeted therapy, time-to-event endpoint is often a desired endpoint. In this paper, we present an event-driven approach for Bayesian one-stage and two-stage single-arm phase II trial
Publikováno v:
Journal of Nanobiotechnology
Journal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-15 (2021)
Journal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-15 (2021)
Backgrounds Sonodynamic therapy (SDT) as an emerging reactive oxygen species (ROS)-mediated antitumor strategy is challenged by the rapid depletion of oxygen, as well as the hypoxic tumor microenvironment. Instead of the presently available coping st
Autor:
Vinay M. Daryani, Andrew M. Davidoff, Wayne L. Furman, Jianrong Wu, Clinton F. Stewart, Sara M. Federico, Alberto S. Pappo, Kenneth J. Caldwell, Mary Beth McCarville, Victor M. Santana, Fariba Navid, Shenghua Mao
Publikováno v:
Eur J Cancer
Background Angiogenesis is critical for tumour growth and metastasis. Dual inhibition of vascular endothelial growth factors and platelet-derived growth factor receptors suppresses angiogenesis. This expansion cohort of a phase I study targeted angio
Autor:
M. Beth McCarville, Alberto S. Pappo, Kirsten K. Ness, Christopher L. Tinkle, Matthew J. Krasin, Barry L. Shulkin, Jianrong Wu, Thomas E. Merchant, Chia-Ho Hua, Armita Bahrami, Sue C. Kaste, Sheri L. Spunt, Shenghua Mao, Andrew M. Davidoff, Daniel M. Green
Publikováno v:
Int J Radiat Oncol Biol Phys
PURPOSE: Our purpose was to assess disease outcomes and late toxicities in pediatric patients with rhabdomyosarcoma treated with conformal photon radiation therapy (RT). METHODS AND MATERIALS: Sixty-eight patients (median age, 6.9 years) were treated
Publikováno v:
Oncotarget
// Aman Chauhan 1 , Tanvir Kabir 2 , Jianrong Wu 3 , Jing Wei 4 , Mary Cook 1 and Charles A. Kunos 5 1 Division of Medical Oncology, University of Kentucky, Lexington, KY, USA 2 College of Medicine, University of Kentucky, Lexington, KY, USA 3 Markey
Autor:
Wayne L. Furman, Fariba Navid, Wing Leung, Alice L. Yu, Matthew J. Krasin, Alberto S. Pappo, Gwendolyn Anthony, Barry L. Shulkin, Armita Bahrami, Stephen D. Gillies, Victor M. Santana, Mary Beth McCarville, Elizabeth Stewart, Michael W. Bishop, Jacquelyn A. Hank, Sara M. Federico, Paul M. Sondel, Rachel C. Brennan, Natasha Sahr, Jianrong Wu, Sara Helmig, April Sykes, Andrew M. Davidoff, Brandon M. Triplett
Publikováno v:
Clin Cancer Res
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 25, iss 21
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 25, iss 21
Purpose: We sought to evaluate whether combining a humanized antidisialoganglioside mAb (hu14.18K322A) with induction chemotherapy improves early responses and outcomes in children with newly diagnosed high-risk neuroblastoma. Patients and Methods: W
Autor:
Jianrong Wu, Jing Wei
Publikováno v:
Stat Med
Immunotherapies are increasingly used for treating patients with advanced-stage cancers. However, cancer immunotherapy trials often present delayed treatment effects and long-term survivors which result non-proportional hazard models and challenge th
Autor:
Noelle L. Williams, Sue C. Kaste, Jamie E. Flerlage, Huiyun Wu, Christopher L. Tinkle, Melissa M. Hudson, Monika L. Metzger, Aimee C Talleur, Jianrong Wu, Barry L. Shulkin, Matthew J. Krasin
Publikováno v:
Radiother Oncol
Background and purpose The use of radiotherapy (RT) for pediatric patients with Hodgkin lymphoma (HL) experiencing disease progression or recurrence (15%) is controversial. We report treatment patterns and outcomes for pediatric patients with refract